DREAM Study
Course Summary
This module covers the DREAM study, which is a multi-centre, open-label, interventional study to evaluate the patient satisfaction of abobotulinumtoxinA treatments in moderate to severe glabellar lines. The study is carried out through a twice-yearly treatment regimen.
Course details
Module Duration: 15 minutes
Learning objectives
• Explain the efficacy of Dysport® and measured patient satisfaction.
• Interpret the effectiveness and safety results.
• Compare the overall study findings.